Residency · Tucson, AZ
Sponsored by University of Arizona College of Medicine-Tucson
International consensus statement on allergy and rhinology: rhinosinusitis 2021.
International forum of allergy & rhinology · 2021 · 768 citations · Eugene Chang
Immediate procedural safety of adjunctive proximal coil occlusion in middle meningeal artery embolization for chronic subdural hematomas: Experience in 137 cases.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026 · 18 citations · Michael Avery
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023 · 120 citations · Tara Carr
Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence-Based Review with Recommendations.
International forum of allergy & rhinology · 2023 · 46 citations · Christopher Le
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Cancer discovery · 2024 · 86 citations · Ricklie Julian
Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade.
The journal of allergy and clinical immunology. In practice · 2023 · 59 citations · Tara Carr
Tackling the Minority Tax: A Roadmap to Redistributing Engagement in Diversity, Equity, and Inclusion Initiatives.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2022 · 65 citations · Erynne Faucett
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial.
The Lancet. Oncology · 2024 · 60 citations · Jared Robbins